Metabolic fingerprint of gestational diabetes mellitus

Journal of Proteomics

Volumn 103, Issue , 2014, Pages 57-71

  Dudzik, Danuta ^a,b   Zorawski, Marcin ^b   Skotnicki, Mariusz ^b   Zarzycki, Wieslaw ^b   Kozlowska, Gabryela ^b   Bibik Malinowska, Katarzyna ^b   Vallejo, María ^a   García, Antonia ^a   Barbas, Coral ^a   Ramos, M Pilar ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Gestational Diabetes Mellitus; Maternal metabolism; Metabolic fingerprinting

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACYLCARNITINE; BILE ACID; BIOLOGICAL MARKER; C PEPTIDE; C REACTIVE PROTEIN; CARNITINE; CHOLESTEROL; CREATININE; FUMARIC ACID; GLUTAMINE; GLYCEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HISTIDINE; HYDROXYBUTYRIC ACID; ICOSANOID; INSULIN; KETONE BODY; LINOLEIC ACID; LIPOXIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDIC ACID; PHENYLALANINE; PYRUVIC ACID; SPHINGOMYELIN; SPHINGOSINE; TRIACYLGLYCEROL; TRYPTOPHAN; VITAMIN; GLUCOSE BLOOD LEVEL; PHOSPHOLIPID;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MASS FRAGMENTOGRAPHY; PILOT STUDY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RECEIVER OPERATING CHARACTERISTIC; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TANDEM MASS SPECTROMETRY; TIME OF FLIGHT MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS; BLOOD; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; PROGNOSIS; PROTEOMICS; URINE;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; HUMANS; PHOSPHOLIPIDS; PILOT PROJECTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROGNOSIS; PROTEOMICS;

EID: 84898781706     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.03.025     Document Type: Article

References (51)

1. Association A.D. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl. 1):S62-S67.
2. International Association of D, Pregnancy Study Groups Consensus P, Metzger B.E., Gabbe S.G., Persson B., Buchanan T.A., et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010, 33:676-682.
3. Lowe L.P., Metzger B.E., Dyer A.R., Lowe J., McCance D.R., Lappin T.R., et al. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care 2012, 35:574-580.
4. Bellamy L., Casas J.P., Hingorani A.D., Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009, 373:1773-1779.
5. Ferrannini E., Natali A., Camastra S., Nannipieri M., Mari A., Adam K.P., et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 2013, 62:1730-1737.
6. Wang-Sattler R., Yu Z., Herder C., Messias A.C., Floegel A., He Y., et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 2012, 8:615.
7. Lowe W.L., Bain J.R. "Prediction is very hard, especially about the future": new biomarkers for type 2 diabetes?. Diabetes 2013, 62:1384-1385.
8. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
9. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
10. Ciborowski M., Javier Ruperez F., Martinez-Alcazar M.P., Angulo S., Radziwon P., Olszanski R., et al. Metabolomic approach with LC-MS reveals significant effect of pressure on diver's plasma. J Proteome Res 2010, 9:4131-4137.
11. Vallejo M., Garcia A., Tunon J., Garcia-Martinez D., Angulo S., Martin-Ventura J.L., et al. Plasma fingerprinting with GC-MS in acute coronary syndrome. Anal Bioanal Chem 2009, 394:1517-1524.
12. Moraes E.P., Ruperez F.J., Plaza M., Herrero M., Barbas C. Metabolomic assessment with CE-MS of the nutraceutical effect of Cystoseira spp extracts in an animal model. Electrophoresis 2011, 32:2055-2062.
13. Gika H.G., Macpherson E., Theodoridis G.A., Wilson I.D. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 871:299-305.
14. Garcia A., Barbas C. Gas chromatography-mass spectrometry (GC-MS)-based metabolomics. Methods Mol Biol 2011, 708:191-204.
15. Dunn W.B., Broadhurst D., Begley P., Zelena E., Francis-McIntyre S., Anderson N., et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 2011, 6:1060-1083.
16. Westerhuis J., Hoefsloot H.J., Smit S., Vis D., Smilde A., Velzen E.J., et al. Assessment of PLSDA cross validation. Metabolomics 2008, 4:81-89.
17. Weinert L.S. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Diabetes Care 2010, 33:e97. [author reply e8].
18. Fanos V., Atzori L., Makarenko K., Melis G.B., Ferrazzi E. Metabolomics application in maternal-fetal medicine. Biomed Res Int 2013, 2013:720514.
19. Sachse D., Sletner L., Morkrid K., Jenum A.K., Birkeland K.I., Rise F., et al. Metabolic changes in urine during and after pregnancy in a large, multiethnic population-based cohort study of gestational diabetes. PLoS One 2012, 7:e52399.
20. Hung N.D., Kim M.R., Sok D.E. 2-Polyunsaturated acyl lysophosphatidylethanolamine attenuates inflammatory response in zymosan A-induced peritonitis in mice. Lipids 2011, 46:893-906.
21. Gall W.E., Beebe K., Lawton K.A., Adam K.P., Mitchell M.W., Nakhle P.J., et al. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One 2010, 5:e10883.
22. Suhre K., Meisinger C., Doring A., Altmaier E., Belcredi P., Gieger C., et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 2010, 5:e13953.
23. Floegel A., Stefan N., Yu Z., Muhlenbruch K., Drogan D., Joost H.G., et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 2013, 62:639-648.
24. Soga T., Ohishi T., Matsui T., Saito T., Matsumoto M., Takasaki J., et al. Lysophosphatidylcholine enhances õglucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem Biophys Res Commun 2005, 326:744-751.
25. Metz S.A. Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release. Diabetes 1986, 35:808-817.
26. Yea K., Kim J., Yoon J.H., Kwon T., Kim J.H., Lee B.D., et al. Lysophosphatidylcholine activates adipocyte glucose uptake and lowers blood glucose levels in murine models of diabetes. J Biol Chem 2009, 284:33833-33840.
27. Yea K., Kim J., Lim S., Kwon T., Park H.S., Park K.S., et al. Lysophosphatidylserine regulates blood glucose by enhancing glucose transport in myotubes and adipocytes. Biochem Biophys Res Commun 2009, 378:783-788.
28. Kroger J., Zietemann V., Enzenbach C., Weikert C., Jansen E.H., Doring F., et al. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011, 93:127-142.
29. Riederer M., Ojala P.J., Hrzenjak A., Graier W.F., Malli R., Tritscher M., et al. Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production. J Lipid Res 2010, 51:2957-2966.
30. Hung N.D., Sok D.E., Kim M.R. Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine. Inflamm Res 2012, 61:473-483.
31. Das U.N. Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules. Prostaglandins Leukot Essent Fatty Acids 2013, 88:201-210.
32. Pietilainen K.H., Sysi-Aho M., Rissanen A., Seppanen-Laakso T., Yki-Jarvinen H., Kaprio J., et al. Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects-a monozygotic twin study. PLoS One 2007, 2:e218.
33. Wallner S., Schmitz G. Plasmalogens the neglected regulatory and scavenging lipid species. Chem Phys Lipids 2011, 164:573-589.
34. Engelmann B. Plasmalogens: targets for oxidants and major lipophilic antioxidants. Biochem Soc Trans 2004, 32:147-150.
35. Ramos Alvarez M.P., Viana M., Alcalá Díaz-Mor M., Bolado V.E., Pita Santibáñez J., Espino M., et al. Gestational diabetes and obesity: role of oxidative stress and inflammation. FEBS Lett 2012, 297 (supp 1):407.
36. Deevska G.M., Nikolova-Karakashian M.N. The twists and turns of sphingolipid pathway in glucose regulation. Biochimie 2011, 93:32-38.
37. Zhu C., Liang Q.L., Hu P., Wang Y.M., Luo G.A. Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy. Talanta 2011, 85:1711-1720.
38. Wang L., Xing X.P., Holmes A., Wadham C., Gamble J.R., Vadas M.A., et al. Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells. Circ Res 2005, 97:891-899.
39. Fox T.E., Bewley M.C., Unrath K.A., Pedersen M.M., Anderson R.E., Jung D.Y., et al. Circulating sphingolipid biomarkers in models of type 1 diabetes. J Lipid Res 2011, 52:509-517.
40. Oda E., Hatada K., Kimura J., Aizawa Y., Thanikachalam P.V., Watanabe K. Relationships between serum unsaturated fatty acids and coronary risk factors: negative relations between nervonic acid and obesity-related risk factors. Int Heart J 2005, 46:975-985.
41. Watson M.L., Coghlan M., Hundal H.S. Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells. Biochem J 2009, 417:791-801.
42. Lefebvre P., Cariou B., Lien F., Kuipers F., Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009, 89:147-191.
43. Staels B., Kuipers F. Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs 2007, 67:1383-1392.
44. Adams S.H., Hoppel C.L., Lok K.H., Zhao L., Wong S.W., Minkler P.E., et al. Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid β-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. J Nutr 2009, 139:1073-1081.
45. Schooneman M.G., Vaz F.M., Houten S.M., Soeters M.R. Acylcarnitines: reflecting or inflicting insulin resistance?. Diabetes 2013, 62:1-8.
46. Trajcevski K.E., O'Neill H.M., Wang D.C., Thomas M.M., Al-Sajee D., Steinberg G.R., et al. Enhanced lipid oxidation and maintenance of muscle insulin sensitivity despite glucose intolerance in a diet-induced obesity mouse model. PLoS One 2013, 8:e71747.
47. Poorabbas A., Fallah F., Bagdadchi J., Mahdavi R., Aliasgarzadeh A., Asadi Y., et al. Determination of free L-carnitine levels in type II diabetic women with and without complications. Eur J Clin Nutr 2007, 61:892-895.
48. Wurtz P., Makinen V.P., Soininen P., Kangas A.J., Tukiainen T., Kettunen J., et al. Metabolic signatures of insulin resistance in 7,098 young adults. Diabetes 2012, 61:1372-1380.
49. Sekhar R.V., McKay S.V., Patel S.G., Guthikonda A.P., Reddy V.T., Balasubramanyam A., et al. Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycine. Diabetes Care 2011, 34:162-167.
50. Montelongo A., Lasuncion M.A., Pallardo L.F., Herrera E. Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 1992, 41:1651-1659.
51. Salek R.M., Maguire M.L., Bentley E., Rubtsov D.V., Hough T., Cheeseman M., et al. A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics 2007, 29:99-108.